image
Healthcare - Biotechnology - NYSE - US
$ 6.84
-1.87 %
$ 94.4 M
Market Cap
-1.72
P/E
BALANCE SHEET
10.2 M ASSETS
-71.66%
18 M LIABILITIES
133.28%
-7.75 M EQUITY
-27.37%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Annovis Bio, Inc.
image
Current Assets 10.2 M
Cash & Short-Term Investments 5.75 M
Receivables 0
Other Current Assets 4.45 M
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 4.28 M
Accounts Payable 1.29 M
Short-Term Debt 0
Other Current Liabilities 2.99 M
Non-Current Liabilities 13.7 M
Long-Term Debt 0
Other Non-Current Liabilities 13.7 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 5.8 28.4 45.7 8.1 1.86 K 35.3 K 0.3
Short Term Investments 0 0 0 0 0 0 0
Receivables 0 0 0 0 0.7 0 0
Inventory 0 0 0 0 (745.6) 0 0
Other Current Assets 41.5 K 0.1 72.8 K 38.2 K 4.14 K 11.9 K 6.69 K
Total Current Assets 10.2 36.0 46.0 8.1 0.7 51 K 0.4
PP&E 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0.4 0 0
Other Assets 0 0 0 0 0 0 0
Total Assets 10.2 36.0 46.0 8.1 1.1 51 K 0.4
LIABILITIES
Accounts Payable 1.3 4.0 0.7 0.3 1.2 68.4 K 71.1 K
Short Term Debt 0 0 0 0 0 0 0
Other Current Liabilities 3.0 3.7 0.8 0.2 0.8 0.5 0.4
Total Current Liabilities 4.3 7.7 1.5 0.6 2.0 0.6 0.5
Long Term Debt 0 0 0 0 0.5 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 13.7 0 0 0 7.2 7.1 6.8
Total Liabilities 18.0 7.7 1.5 0.6 9.7 7.6 7.3
EQUITY
Common Stock 1.05 K 816 810 689 28 28 27
Retained Earnings (110.3) (54.1) (28.7) (14.2) (8.8) (7.8) (7.1)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 (7.1) (7.1) (6.8)
Total Equity (7.8) 28.3 44.5 7.5 (8.6) (7.6) (7.0)
Total Liabilities and Equity 10.2 36.0 46.0 8.1 1.1 51 K 0.4
SHARES OUTSTANDING
Common Shares Outstanding 9.0 8.2 7.6 6.3 4.5 4.4 4.4